关注
Wayne Martin
Wayne Martin
在 ualberta.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Levodopa and the progression of Parkinson's disease
Parkinson Study Group
New England Journal of Medicine 351 (24), 2498-2508, 2004
23012004
Unified Huntington's disease rating scale: reliability and consistency
K Kieburtz, JB Penney, P Como, N Ranen, I Shoulson, A Feigin, ...
Movement disorders 11 (2), 136-142, 1996
20101996
Brain Blood Flow Measured with Intravenous H215O.: II. Implementation and Validation
ME Raichle, WRW Martin, P Herscovitch, MA Mintun, J Markham
Journal of Nuclear Medicine 24 (9), 790-798, 1983
13361983
Diffusion tensor imaging of white matter tract evolution over the lifespan
C Lebel, M Gee, R Camicioli, M Wieler, W Martin, C Beaulieu
Neuroimage 60 (1), 340-352, 2012
11702012
Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL‐PET study
AL Whone, RL Watts, AJ Stoessl, M Davis, S Reske, C Nahmias, AE Lang, ...
Annals of neurology 54 (1), 93-101, 2003
10492003
Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group
DE Hobson, AE Lang, WRW Martin, A Razmy, J Rivest, J Fleming
Jama 287 (4), 455-463, 2002
7332002
Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography.
MA Mintun, ME Raichle, WR Martin, P Herscovitch
Journal of nuclear medicine: official publication, Society of Nuclear …, 1984
7261984
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study
Parkinson Study Group
Archives of Neurology 59 (12), 1937-1943, 2002
6952002
Practice parameter: initiation of treatment for Parkinson’s disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology
JM Miyasaki, W Martin, O Suchowersky, WJ Weiner, AE Lang
Neurology 58 (1), 11-17, 2002
5842002
A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease
Parkinson Study Group
Archives of Neurology 61 (4), 561-566, 2004
5782004
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease
Huntington Study Group
Neurology 57 (3), 397-404, 2001
5042001
Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study
K Duff, JS Paulsen, LJ Beglinger, DR Langbehn, JC Stout, ...
Biological psychiatry 62 (12), 1341-1346, 2007
4662007
Midbrain iron content in early Parkinson disease: a potential biomarker of disease status
WRW Martin, M Wieler, M Gee
Neurology 70 (16_part_2), 1411-1417, 2008
4572008
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
4272012
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
DB Calne, JW Langston, WRW Martin, AJ Stoessl, TJ Ruth, MJ Adam, ...
Nature 317 (6034), 246-248, 1985
4251985
Preparing for preventive clinical trials: the Predict-HD study
JS Paulsen, M Hayden, JC Stout, DR Langbehn, E Aylward, CA Ross, ...
Archives of neurology 63 (6), 883-890, 2006
3902006
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
Ninds Net-Pd Investigators
Neurology 66 (5), 664-671, 2006
3872006
Nigrostriatal function in humans studied with positron emission tomography
WRW Martin, MR Palmer, CS Patlak, DB Calne
Annals of Neurology: Official Journal of the American Neurological …, 1989
3481989
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit
MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ...
JAMA neurology 71 (5), 543-552, 2014
2992014
Longitudinal change in regional brain volumes in prodromal Huntington disease
EH Aylward, PC Nopoulos, CA Ross, DR Langbehn, RK Pierson, JA Mills, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (4), 405-410, 2011
2972011
系统目前无法执行此操作,请稍后再试。
文章 1–20